This inventor holds 16 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Roche Glycart Ag, Inbiomotion S.l., Glycart Biotechnology Ag. Active years: 2009-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Barcelona, CH (2011)
- Zürich, CH (2009 - 2015)
- Barcelona, ES (2015 - 2024)
Company Filing History:
8 out of 73 
6 out of 10 
1 out of 7 Years Active: 2009-2024
Title: The Innovative Contributions of Joël Jean-Mairet in Cancer Research
Introduction
Joël Jean-Mairet is a prominent inventor based in Barcelona, Spain, recognized for his significant contributions to the field of cancer research. With a total of 16 patents to his name, his work primarily focuses on innovative methodologies for diagnosing and treating prostate cancer metastasis.
Latest Patents
Among his latest patents, Joël has developed methods for the diagnosis, prognosis, and treatment of prostate cancer metastasis. One notable invention involves determining whether the c-MAF gene is amplified in a primary tumor sample, which plays a crucial role in diagnosing or predicting the progression of prostate cancer. He has also established a method for assessing the expression level of the c-MAF gene to understand the likelihood of developing bone metastases compared to other organs. Furthermore, his inventions include the use of c-MAF inhibitors as therapeutic targets for treating prostate cancer, showcasing his commitment to advancing medical treatment options.
Career Highlights
Throughout his career, Joël Jean-Mairet has collaborated with leading companies in the field of biotechnology, including Roche Glycart AG and Inbiomotion S.L. His extensive work has placed him at the forefront of cancer research, allowing him to contribute valuable insights into the mechanisms of prostate cancer metastasis and innovative therapeutic strategies.
Collaborations
Joël has worked alongside notable professionals such as Pablo Umaña and James E. Bailey, which highlights the collaborative nature of his research efforts. These collaborations have not only enriched his own work but have also fostered advancements in the broader scientific community.
Conclusion
Joël Jean-Mairet stands out as an influential inventor whose work in the diagnosis and treatment of prostate cancer is contributing to life-saving innovations in the medical field. His continued research and development in this area underscore the importance of innovation in improving cancer care and outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile